Choosing between TelosRX and CLYR Health for GLP-1 weight loss comes down to one question: do you want one rate that holds, or a rate that follows your dose? CLYR prices its compounded GLP-1 by the weekly dose you are actually on, and publishes every tier openly before you start. TelosRX starts as low as $99 per month for semaglutide, holds that rate flat as your dose is titrated, and includes quarterly labs. Both are cash-pay, both run on an online intake, and neither ships anything without a licensed provider signing off.
Want every dose and every billed-once total published on the page before you commit, plus a program you can stop from a portal without a subscription? CLYR Health is unusually transparent and worth a look. Want a lower entry price, a rate that does not move when your dose does, a needle-free option you can start today, and quarterly labs? TelosRX is the better fit.
Start your intake →Quick comparison: TelosRX vs CLYR Health
Compounded medications are not FDA-approved. Any prescription is subject to medical approval by a licensed provider, and approval is never guaranteed. Pricing and program details are as published by each company at the time of writing.
What is TelosRX?
TelosRX is an online-first, LegitScript-certified telehealth service focused on GLP-1 weight management. It works asynchronously. You complete a short intake, a US-licensed provider reviews it, and there is no appointment to book at any point.
The GLP-1 line covers four paths rather than one. Injectable semaglutide is the entry point at as low as $99 per month. Injectable tirzepatide is as low as $139 per month. There is a needle-free daily oral GLP-1 from $9 a day. For a gentler start, microdosed tirzepatide runs as low as $116 per month. All four sit side by side on the GLP-1 options page.
Every plan includes unlimited messaging with a 24/7 care team, dose adjustments as your body responds, quarterly labs, and free 2-day discreet shipping. Your rate stays flat as your dose is titrated. If a licensed provider decides a GLP-1 is not right for you, you pay nothing and nothing ships.
Medications are compounded by licensed US pharmacies, and TelosRX names them publicly: VialsRX and Jungle Jim's. Clinical care is delivered through Arora Health Group. You can start your evaluation without booking an appointment.
What is CLYR Health?
CLYR Health, at clyr.health, is a cash-pay telehealth platform covering weight loss, sexual health, hair, and general wellness. It describes itself as a technology platform rather than a medical practice. Clinical care comes from an independent medical group, and CLYR names that network publicly as MD Integrations.
Its weight-loss line is built on two compounded medications. Compounded semaglutide is formulated with vitamin B12, and compounded tirzepatide is formulated with B12 as well. Both are once-weekly subcutaneous injections, compounded by a state-licensed compounding pharmacy and shipped in an insulated cooler with the supplies to inject at home. A lipotropic injection is offered separately as a metabolic companion.
CLYR also lists brand-name products with published prices and a waitlist rather than a checkout. Zepbound is listed at $499 per month for the starting dose. Wegovy tablets and Foundayo, the oral orforglipron tablet, are both listed at $299 per month to start. These are announced rather than dispensing, so they are worth watching but are not something you can begin today.
The catalog runs wider than weight loss. Alongside the GLP-1 program, CLYR sells sexual-health treatments, hair products, wellness injections, and an antiparasitic line covering ivermectin and mebendazole. Breadth like that is a business choice rather than a clinical one, but it is worth knowing what kind of company you are signing up with.
CLYR displays a LegitScript seal on its site. Its telehealth consent discloses a $20 professional medical consultation fee, which is included in the amount you pay.
Medications: what each program offers
Both services work in the same drug class. Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on both the GLP-1 and GIP receptors. Both slow gastric emptying and act on appetite signaling. That is the mechanism behind reduced hunger and smaller portions.
The compounded versions offered by both TelosRX and CLYR are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision. CLYR states plainly on its weight-loss page that brand products are not sold there, and its brand pages remain waitlist-only for now.
The practical difference is format and timing. CLYR publishes two delivery routes today, and both are weekly injections. TelosRX publishes four, including a daily under-the-tongue option that removes needles from the routine entirely, and a microdosed tirzepatide protocol for people who want to ease in gently. If needles are the thing standing between you and starting, you can begin a needle-free oral GLP-1 now rather than joining a list.
For background on this drug class, see the NIH NIDDK overview of prescription weight-management medications and the FDA's questions and answers on drug compounding.
Key takeaway: CLYR publishes every dose tier honestly, then charges more as you climb. TelosRX publishes one rate and holds it, starts $31 a month lower on semaglutide, and includes labs.
Pricing and what the rate covers
Give CLYR credit where it is due. Its pricing is more openly published than most of this field. Every dose, every duration, and the billed-once total are visible on the product page before you answer a single question. Nothing is hidden behind a quiz, and the site says so directly.
The structure is tiered by weekly dose. For compounded semaglutide, CLYR lists three maintaining tiers. The lowest is 8 units a week, at $130 per month on an 8-week cycle or $169 billed monthly. The middle tier is 18 units at $160 or $199, and the top tier is 30 units at $190 or $229. A three-month titration program that walks you up through those doses is listed at $189 per month.
Compounded tirzepatide follows the same logic. A starter month is $149 for the first vial, then refills run $199 per month on 8-week cycles or $249 billed monthly. Higher maintaining doses step up from there, reaching $329 per month at 70 units a week and $399 billed monthly at 90 units or more.
CLYR's own reasoning for this is sound: a higher weekly dose uses a larger vial, so you pay for the vial you are actually on. It also promises no surprise tiers at checkout, and its starter month is designed to cover the whole early climb without a mid-titration price jump. That is a fair and well-explained model.
TelosRX takes the other approach and publishes four rates that do not move:
- Semaglutide, injectable, as low as $99 per month
- Microdosed tirzepatide, as low as $116 per month
- Tirzepatide, injectable, as low as $139 per month
- Oral GLP-1, needle-free and daily, from $9 a day
The gap opens up as you titrate. At the bottom of the ladder the two are close, with $99 against $130. Further up, a CLYR semaglutide patient at 30 units a week is looking at $190 to $229, while a TelosRX semaglutide rate stays where it started. The same pattern holds on tirzepatide.
Neither company bills insurance. TelosRX plans are FSA and HSA eligible. CLYR includes the provider consultation, the medication, the injection kit, and shipping in its published price. It is also not a subscription. Each term is billed once, nothing renews unless you choose it, and you can stop from your portal.
Start your intake to see your plan price in a few minutes.
How the process works
The two models are close here. Both are online, both put a licensed provider between you and a prescription, and neither prescribes automatically.
With TelosRX, the intake takes about five minutes, a licensed provider reviews it asynchronously, and approved medication ships free with 2-day delivery. Nothing is charged unless you are approved.
With CLYR, you pick a product, see the price, and answer a short set of questions. A licensed US provider reviews your history, weight goals, and current medications, then writes a prescription if it is appropriate. Communication happens by audio, video, or secure messaging depending on what the provider needs.
CLYR does one thing here that deserves a mention. If you are already on a GLP-1 elsewhere, you can tell them your current weekly dose. A provider can then continue it, rather than making you restart at the bottom of the ladder. Anyone who has switched providers mid-titration knows how much that matters.
Begin your TelosRX intake and a licensed provider will review it.
Coaching and ongoing support
Neither company sells a heavy coaching layer. There is no nutritionist program, group session schedule, or app-based curriculum published by either one. Support in both cases means access to clinical people.
CLYR includes ongoing provider care and dose management in every plan, handled through a patient portal, with text updates about your treatment status. Dose titration is provider-led, and switching or maintaining a dose runs through the same review.
TelosRX includes unlimited messaging with a 24/7 care team, dose adjustments as your body changes, and quarterly labs. CLYR does not publish a lab program anywhere on its site. If bloodwork tracking is part of what you want from a weight-loss program, that is a real difference rather than a marketing one.
Neither approach is automatically better. CLYR keeps the whole thing simple and self-serve, which suits people who know what they want. TelosRX folds monitoring into the plan for people who would rather have it built in.
Safety, oversight, and disclosure
Both companies gate medication behind a licensed provider, and both say so clearly. GLP-1 medications are not appropriate for everyone. Providers screen for a personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, gallbladder disease, pregnancy and breastfeeding, type 1 diabetes, and active eating disorders. Nausea and digestive changes are common early on.
CLYR's disclosure is solid. It publishes the contraindications on its weight-loss page, states that compounded medications are not FDA-approved, and makes clear that it is neither a pharmacy nor a medical practice. Its telehealth consent explains that providers may be physicians, nurse practitioners, or physician assistants. It also tells you how to raise a concern with your state licensing board, and discloses the consultation fee upfront.
Both companies display a LegitScript seal, so certification is not a point of difference between them. If you want to confirm the current status of any telehealth company, including either of these, LegitScript's own verification tool is the only reliable place to check.
Where the two do differ is pharmacy disclosure. TelosRX names VialsRX and Jungle Jim's for pharmacy and Arora Health Group for clinical care. CLYR names MD Integrations as its provider network, which is more than many competitors disclose, but describes its pharmacy only as a state-licensed compounding pharmacy without naming it. Knowing exactly who is preparing your medication is worth something.
Ready to compare in practice rather than on paper? Check your eligibility in about five minutes.
Which service is right for you?
Best for a lower entry price, a rate that stays flat as your dose climbs, a needle-free daily option you can start now, quarterly labs, and named pharmacy partners.
Best for fully published dose-by-dose pricing, a no-subscription structure you can stop from a portal, dose continuation if you are switching providers, and a wide non-GLP-1 catalog.
If you are choosing on entry price, price stability through titration, needle-free access, or lab monitoring, TelosRX is the stronger fit. If you want every tier laid out before you commit, no recurring billing, and the ability to carry your current dose across, CLYR Health earns a serious look.
Frequently Asked Questions
Is TelosRX legitimate?
Yes. TelosRX is a LegitScript-certified telehealth service. Medications are compounded by licensed US pharmacies, VialsRX and Jungle Jim's, and clinical care is provided through Arora Health Group. Every prescription is subject to medical approval by a licensed provider.
How much does TelosRX cost compared to CLYR Health?
TelosRX publishes four rates that stay flat as your dose is titrated. Semaglutide is as low as $99 per month, microdosed tirzepatide as low as $116, injectable tirzepatide as low as $139, and needle-free oral GLP-1 from $9 a day. CLYR prices by weekly dose instead. Compounded semaglutide starts at $130 per month on an 8-week cycle, compounded tirzepatide has a $149 starter month, and both step up as your dose increases.
Why does CLYR Health charge more as your dose goes up?
CLYR explains that a higher weekly dose uses a larger vial, so you pay for the vial you are prescribed. Every tier is published on its product pages before you start, and it says there are no surprise tiers at checkout. TelosRX takes the other approach and holds one rate through titration.
Are the GLP-1 medications FDA-approved?
No. The compounded semaglutide and tirzepatide offered by both TelosRX and CLYR Health are not FDA-approved. They are prepared by licensed US compounding pharmacies under provider supervision, and only a licensed provider can decide whether a compounded medication is appropriate for you.
Does CLYR Health offer a needle-free GLP-1?
Not yet. CLYR lists oral brand products, including Wegovy tablets and Foundayo, with published prices and a waitlist rather than a checkout. Its two GLP-1 medications available today are both once-weekly injections. TelosRX offers a daily oral GLP-1 taken under the tongue right now, alongside three injectable options.
Can I switch from CLYR Health to TelosRX?
Many people compare programs before deciding. You can start a new TelosRX intake at any time. A provider reviews your history, current medications, and goals before anything is approved, and you pay nothing if a provider decides a GLP-1 is not right for you.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Any prescription is subject to evaluation by a licensed provider, and approval is never guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. Competitor details are as published on clyr.health at the time of writing and may change.
Start your private evaluation at TelosRX, or compare every plan on the GLP-1 options page.